Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Levonorgestrel + Ethinyl estradiol
- Therapeutic area
- Reproductive & genitourinary
- Drug class
- Sex hormones / contraceptives
- ATC
- G03AA
- Strength
- 0.15 mg + 0.03 mg
- Dosage form
- Tablet
- Pack
- 28's
- Registration no.
- 015607
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Zafa Pharmaceutical Laboratories (Pvt) Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Famila (Levonorgestrel + Ethinyl estradiol) is used for
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Levonorgestrel + Ethinyl estradiol is right for you and the dose.
- Acne: A combined contraceptive pill can help acne in women who also want contraception or have PCOS
- Period pain (dysmenorrhoea): Second-line option for people who do not want to get pregnant, usually tried for three to six months
- Polycystic ovary syndrome (PCOS): First choice for irregular periods, extra hair and acne in women not trying to get pregnant
About Famila 0.15 mg + 0.03 mg tablet
Famila 0.15 mg + 0.03 mg tablet contains Levonorgestrel + Ethinyl estradiol 0.15 mg + 0.03 mg. It is registered with DRAP by Zafa Pharmaceutical Laboratories (Pvt) Ltd (registration no. 015607). Its official price is PKR 64.18 for a pack of 28's, about PKR 2.29 per tablet. This price has applied since 27 July 2026. Famila is also available as 150 mg injection. 1 other brand of Levonorgestrel + Ethinyl estradiol 0.15 mg + 0.03 mg (tablet) is registered in Pakistan. Compare all brands and prices →
Other strengths of Famila
All 1 other brands of Levonorgestrel + Ethinyl estradiol 0.15 mg + 0.03 mg tablet in Pakistan
These 1 brands are alternatives (substitutes) to Famila: each contains Levonorgestrel + Ethinyl estradiol 0.15 mg + 0.03 mg tablet. Ask your doctor or pharmacist before you switch brands.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Novodol | Zafa Pharmaceutical Laboratories (Pvt) Ltd | 28's | PKR 64.17 | PKR 2.29 / tablet |
See every strength and form of Levonorgestrel + Ethinyl estradiol →
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Famila, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Zafa Pharmaceutical Laboratories (Pvt) Ltd., Karachi
- DRAP registration
- 015607
- Phone
- +92 21 36807100
- contact@zafa.com.pk
- Website
- https://zafa.com.pk/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (28's). Current price PKR 64.18, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Famila 0.15 mg + 0.03 mg, 28's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/famila-0-15-mg-0-03-mg-015607-28s-m-s-zafa-pharmaceutical-laboratories-pvt-ltd/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 64.18 | 2026-07-27 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Cite this record
Medicine record · DRAP registration 015607Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.